Literature DB >> 36125265

Insulin and Insulin-Like Growth Factor 1 Signaling Preserves Sarcomere Integrity in the Adult Heart.

Christian Riehle1,2,3, Eric T Weatherford1,2, Nicholas S McCarty1,2, Alec Seei1,2, Bharat P Jaishy1,2, Rajkumar Manivel1,2, Paolo Galuppo3, Chantal Allamargot4, Tariq Hameed5, Ryan L Boudreau5,6, Johann Bauersachs3, Robert M Weiss5,6, E Dale Abel1,2,6.   

Abstract

Insulin and insulin-like growth factor 1 (IGF1) signaling is transduced by insulin receptor substrate 1 (IRS1) and IRS2. To elucidate physiological and redundant roles of insulin and IGF1 signaling in adult hearts, we generated mice with inducible cardiomyocyte-specific deletion of insulin and IGF1 receptors or IRS1 and IRS2. Both models developed dilated cardiomyopathy, and most mice died by 8 weeks post-gene deletion. Heart failure was characterized by cardiomyocyte loss and disarray, increased proapoptotic signaling, and increased autophagy. Suppression of autophagy by activating mTOR signaling did not prevent heart failure. Transcriptional profiling revealed reduced serum response factor (SRF) transcriptional activity and decreased mRNA levels of genes encoding sarcomere and gap junction proteins as early as 3 days post-gene deletion, in concert with ultrastructural evidence of sarcomere disruption and intercalated discs within 1 week after gene deletion. These data confirm conserved roles for constitutive insulin and IGF1 signaling in suppressing autophagic and apoptotic signaling in the adult heart. The present study also identifies an unexpected role for insulin and IGF1 signaling in regulating an SRF-mediated transcriptional program, which maintains expression of genes encoding proteins that support sarcomere integrity in the adult heart, reduction of which results in rapid development of heart failure.

Entities:  

Keywords:  cardiac remodeling; cardiac structure; heart failure; insulin signaling

Mesh:

Substances:

Year:  2022        PMID: 36125265      PMCID: PMC9583714          DOI: 10.1128/mcb.00163-22

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   5.069


  62 in total

1.  Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy.

Authors:  Jaetaek Kim; Adam R Wende; Sandra Sena; Heather A Theobald; Jamie Soto; Crystal Sloan; Benjamin E Wayment; Sheldon E Litwin; Martin Holzenberger; Derek LeRoith; E Dale Abel
Journal:  Mol Endocrinol       Date:  2008-09-18

2.  Contractile dysfunction in hypertrophied hearts with deficient insulin receptor signaling: possible role of reduced capillary density.

Authors:  Alfred P McQueen; Dongfang Zhang; Ping Hu; Leanne Swenson; Ying Yang; Vlad G Zaha; James L Hoffman; Ui Jeong Yun; Gopa Chakrabarti; Zhengming Wang; Kurt H Albertine; E D Abel; Sheldon E Litwin
Journal:  J Mol Cell Cardiol       Date:  2005-10-10       Impact factor: 5.000

3.  Insulin receptor substrates Irs1 and Irs2 coordinate skeletal muscle growth and metabolism via the Akt and AMPK pathways.

Authors:  Yun Chau Long; Zhiyong Cheng; Kyle D Copps; Morris F White
Journal:  Mol Cell Biol       Date:  2010-12-06       Impact factor: 4.272

4.  Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents.

Authors:  Ippei Shimizu; Tohru Minamino; Haruhiro Toko; Sho Okada; Hiroyuki Ikeda; Noritaka Yasuda; Kaoru Tateno; Junji Moriya; Masataka Yokoyama; Aika Nojima; Gou Young Koh; Hiroshi Akazawa; Ichiro Shiojima; C Ronald Kahn; E Dale Abel; Issei Komuro
Journal:  J Clin Invest       Date:  2010-04-19       Impact factor: 14.808

5.  Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression.

Authors:  Darrell D Belke; Sandrine Betuing; Martin J Tuttle; Christophe Graveleau; Martin E Young; Mark Pham; Dongfang Zhang; Robert C Cooksey; Donald A McClain; Sheldon E Litwin; Heinrich Taegtmeyer; David Severson; C Ronald Kahn; E Dale Abel
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

6.  Estrogen Protects Cardiac Function and Energy Metabolism in Dilated Cardiomyopathy Induced by Loss of Cardiac IRS1 and IRS2.

Authors:  Hui Yan; Wanbao Yang; Fenghua Zhou; Quan Pan; Kimberly Allred; Clinton Allred; Yuxiang Sun; David Threadgill; David Dostal; Carl Tong; Shaodong Guo
Journal:  Circ Heart Fail       Date:  2022-05-17       Impact factor: 8.790

7.  Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1.

Authors:  H Tamemoto; T Kadowaki; K Tobe; T Yagi; H Sakura; T Hayakawa; Y Terauchi; K Ueki; Y Kaburagi; S Satoh
Journal:  Nature       Date:  1994-11-10       Impact factor: 49.962

8.  Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload.

Authors:  Ping Hu; Dongfang Zhang; LeAnne Swenson; Gopa Chakrabarti; E Dale Abel; Sheldon E Litwin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-05-08       Impact factor: 4.733

9.  A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance.

Authors:  J C Brüning; M D Michael; J N Winnay; T Hayashi; D Hörsch; D Accili; L J Goodyear; C R Kahn
Journal:  Mol Cell       Date:  1998-11       Impact factor: 17.970

10.  Activation of Foxo1 by insulin resistance promotes cardiac dysfunction and β-myosin heavy chain gene expression.

Authors:  Yajuan Qi; Qinglei Zhu; Kebin Zhang; Candice Thomas; Yuxin Wu; Rajesh Kumar; Kenneth M Baker; Zihui Xu; Shouwen Chen; Shaodong Guo
Journal:  Circ Heart Fail       Date:  2014-12-04       Impact factor: 10.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.